1. Promotional Labeling and Advertising Considerations for Prescription B  fda.gov
  2. FDA finalizes guidance on promotional materials for biologics and biosimilars  Fierce Pharma
  3. BRIEF—FDA final guidance on promotional labeling and advertising for biosimilars  The Pharma Letter
  4. Is FDA Streamlining Regulations in the Biosimilar Space?  Pharmaceutical Executive
  5. Parexel Exec On How CROs Should Prepare For Biosimilar Pathway, AI-Led Changes  Citeline News & Insights